Terms: = Ovarian cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
39 results:
1. Diagnostic performance of CA125, HE4, ROMA, and CPH-I in identifying primary ovarian cancer.
Luo HJ; Hu ZD; Cui M; Zhang XF; Tian WY; Ma CQ; Ren YN; Dong ZL
J Obstet Gynaecol Res; 2023 Mar; 49(3):998-1006. PubMed ID: 36609691
[TBL] [Abstract] [Full Text] [Related]
2. Preparation and Performance of Chemotherapy Drug-Loaded Graphene Oxide-Based Nanosheets That Target ovarian cancer Cells via Folate Receptor Mediation.
Wang J; Han S; Zhang Z; Wang J; Zhang G
J Biomed Nanotechnol; 2021 May; 17(5):960-970. PubMed ID: 34082881
[TBL] [Abstract] [Full Text] [Related]
3. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract] [Full Text] [Related]
4. Utilization of virtual low-keV monoenergetic images generated using dual-layer spectral detector computed tomography for the assessment of peritoneal seeding from ovarian cancer.
Kim TM; Kim SY; Cho JY; Kim SH; Moon MH
Medicine (Baltimore); 2020 Jun; 99(23):e20444. PubMed ID: 32501991
[TBL] [Abstract] [Full Text] [Related]
5. Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
Brown TA; Byrd K; Vreeland TJ; Clifton GT; Jackson DO; Hale DF; Herbert GS; Myers JW; Greene JM; Berry JS; Martin J; Elkas JC; Conrads TP; Darcy KM; Hamilton CA; Maxwel GL; Peoples GE
Cancer Med; 2019 Aug; 8(10):4678-4687. PubMed ID: 31274231
[TBL] [Abstract] [Full Text] [Related]
6. Phase Ib trial of folate binding protein (fbp)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
Vreeland TJ; Litton JK; Qiao N; Philips AV; Alatrash G; Hale DF; Jackson DO; Peace KM; Greene JM; Berry JS; Clifton GT; Peoples GE; Mittendorf EA
Clin Immunol; 2018 Jul; 192():6-13. PubMed ID: 29574039
[TBL] [Abstract] [Full Text] [Related]
7. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.
Jackson DO; Byrd K; Vreeland TJ; Hale DF; Herbert GS; Greene JM; Schneble EJ; Berry JS; Trappey AF; Clifton GT; Hardin MO; Martin J; Elkas JC; Conrads TP; Darcy KM; Hamilton CA; Maxwell GL; Peoples GE
Oncotarget; 2017 Feb; 8(9):15912-15923. PubMed ID: 27852036
[TBL] [Abstract] [Full Text] [Related]
8. MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.
Pénzváltó Z; Lánczky A; Lénárt J; Meggyesházi N; Krenács T; Szoboszlai N; Denkert C; Pete I; Győrffy B
BMC Cancer; 2014 Nov; 14():837. PubMed ID: 25408231
[TBL] [Abstract] [Full Text] [Related]
9. Impact of adaptive iterative dose reduction (AIDR) 3D on low-dose abdominal CT: comparison with routine-dose CT using filtered back projection.
Matsuki M; Murakami T; Juri H; Yoshikawa S; Narumi Y
Acta Radiol; 2013 Oct; 54(8):869-75. PubMed ID: 23761554
[TBL] [Abstract] [Full Text] [Related]
10. Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.
Stordal B; Hamon M; McEneaney V; Roche S; Gillet JP; O'Leary JJ; Gottesman M; Clynes M
PLoS One; 2012; 7(7):e40717. PubMed ID: 22792399
[TBL] [Abstract] [Full Text] [Related]
11. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.
Karagiannis SN; Bracher MG; Beavil RL; Beavil AJ; Hunt J; McCloskey N; Thompson RG; East N; Burke F; Sutton BJ; Dombrowicz D; Balkwill FR; Gould HJ
Cancer Immunol Immunother; 2008 Feb; 57(2):247-63. PubMed ID: 17657488
[TBL] [Abstract] [Full Text] [Related]
12. In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.
Müller C; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1162-70. PubMed ID: 16721570
[TBL] [Abstract] [Full Text] [Related]
13. Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.
Theti DS; Bavetsias V; Skelton LA; Titley J; Gibbs D; Jansen G; Jackman AL
Cancer Res; 2003 Jul; 63(13):3612-8. PubMed ID: 12839949
[TBL] [Abstract] [Full Text] [Related]
14. The comparison of cytotoxic T-lymphocyte effects of dendritic cells stimulated by the folate binding protein peptide cultured with IL-15 and IL-2 in solid tumor.
Kim DK; Kim JH; Kim YT; Kim JW; Ioannides CG
Yonsei Med J; 2002 Dec; 43(6):691-700. PubMed ID: 12497651
[TBL] [Abstract] [Full Text] [Related]
15. Identification of activated tumor antigen-reactive CD8+ cells in healthy individuals.
Lee TV; Anderson BW; Peoples GE; Castilleja A; Murray JL; Gershenson DM; Ioannides CG
Oncol Rep; 2000; 7(3):455-66. PubMed ID: 10767352
[TBL] [Abstract] [Full Text] [Related]
16. Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.
Kim DK; Lee TV; Castilleja A; Anderson BW; Peoples GE; Kudelka AP; Murray JL; Sittisomwong T; Wharton JT; Kim JW; Ioannides CG
Anticancer Res; 1999; 19(4B):2907-16. PubMed ID: 10652572
[TBL] [Abstract] [Full Text] [Related]
17. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.
Peoples GE; Anderson BW; Lee TV; Murray JL; Kudelka AP; Wharton JT; Ioannides CG
Clin Cancer Res; 1999 Dec; 5(12):4214-23. PubMed ID: 10632363
[TBL] [Abstract] [Full Text] [Related]
18. Bispecific antibody-mediated lysis of primary cultures of ovarian carcinoma cells using multiple target antigens.
Smans KA; Ingvarsson MB; Lindgren P; Canevari S; Walt H; Stigbrand T; Bäckström T; Millán JL
Int J Cancer; 1999 Oct; 83(2):270-7. PubMed ID: 10471538
[TBL] [Abstract] [Full Text] [Related]
19. ovarian cancer-associated lymphocyte recognition of folate binding protein peptides.
Peoples GE; Anderson BW; Fisk B; Kudelka AP; Wharton JT; Ioannides CG
Ann Surg Oncol; 1998 Dec; 5(8):743-50. PubMed ID: 9869522
[TBL] [Abstract] [Full Text] [Related]
20. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells.
Li S; Deshmukh HM; Huang L
Pharm Res; 1998 Oct; 15(10):1540-5. PubMed ID: 9794495
[TBL] [Abstract] [Full Text] [Related]
[Next]
